Prezzo di chiusura
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
3,69 CNY | -1,07% | 0,00% | -12,97% |
Attività
Vendite per attività
CNY in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Traditional Chinese Medicine Formula Granules and Decoction Pieces
47,9
%
| 3 360 | 50,5 % | 2 923 | 47,9 % | -12,99% |
Blood-essential Injection
13,9
%
| 817 | 12,3 % | 851 | 13,9 % | +4,23% |
Smart Pharmaceutical Supply Chain
11,7
%
| 588 | 8,8 % | 715 | 11,7 % | +21,66% |
Medical Device
6,3
%
| 674 | 10,1 % | 383 | 6,3 % | -43,12% |
Excipients
5,6
%
| 361 | 5,4 % | 344 | 5,6 % | -4,80% |
Low Molecular Weight Heparin Calcium Injection
4,7
%
| 305 | 4,6 % | 287 | 4,7 % | -5,82% |
Moxifloxacin Hydrochloride Sodium Chloride Injection
3,1
%
| 165 | 2,5 % | 189 | 3,1 % | +14,49% |
Other Products
3,1
%
| 233 | 3,5 % | 189 | 3,1 % | -18,85% |
API
2,6
%
| 147 | 2,2 % | 156 | 2,6 % | +6,07% |
Enoxaparin Sodium Injection
1,2
%
| - | - | 71 | 1,2 % | - |
Vendite per regione
CNY in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
China
93,5
%
| 5 923 | 89,1 % | 5 167 | 93,5 % | -12,77% |
Overseas
6,5
%
| 727 | 10,9 % | 361 | 6,5 % | -50,29% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Dan Zheng
CEO | Chief Executive Officer | 60 | - |
Wu Jun Lan
DFI | Director of Finance/CFO | 49 | - |
Wu Sun
BRD | Director/Board Member | 55 | - |
Dan Liang
BRD | Director/Board Member | 43 | 16/04/13 |
Rui Qiang Chen
HRO | Human Resources Officer | 47 | 25/06/15 |
Qin Pan
PRN | Corporate Officer/Principal | 54 | 26/04/19 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Xiao Qing Yao
FOU | Founder | 59 | 23/09/96 |
Li Li
BRD | Director/Board Member | 63 | 18/11/20 |
Dan Zheng
CEO | Chief Executive Officer | 60 | - |
Wu Jun Lan
DFI | Director of Finance/CFO | 49 | - |
Da Wei Miao
BRD | Director/Board Member | 69 | 08/05/07 |
Dan Liang
BRD | Director/Board Member | 43 | 16/04/13 |
Tao Gong
BRD | Director/Board Member | 55 | 16/01/20 |
Sheng Tian Wang
BRD | Director/Board Member | 73 | 28/12/17 |
Xu Feng Pu
BRD | Director/Board Member | 61 | 16/01/20 |
Wu Sun
BRD | Director/Board Member | 55 | - |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 3 004 154 837 | 826 252 275 ( 27,50 %) | 0 | 27,50 % |
Coordinate società
Tianjin Chase Sun Pharmaceutical Co., Ltd.
B01 Building Entrepreneurship Headquarters Base
301700, Tianjin
+86 22 5962 3160
http://www.chasesun.cnSettore
Vendite per attività
Vendite per regione
Revisioni EPS
Utili annuali - Indice di sorpresa
Variaz. 1 gen. | Capi. | |
---|---|---|
-12,97% | 1,53 Mrd | |
+35,04% | 5,92 Mrd | |
-15,13% | 4,51 Mrd | |
-9,75% | 3,15 Mrd | |
+2,14% | 3,1 Mrd | |
-6,82% | 2,42 Mrd | |
+47,87% | 1,97 Mrd | |
-7,89% | 1,68 Mrd | |
+0,09% | 1,65 Mrd | |
+33,40% | 1,38 Mrd |
- Borsa valori
- Azioni
- Azione 300026
- Società Tianjin Chase Sun Pharmaceutical Co.,Ltd